Finance
Implantable tissue company files shelf registration statement
Published in Medical Letter on the CDC and FDA, January 23rd, 2005
Upon being declared effective by the SEC, the registration statement will allow CryoLife to sell from time to time up to $50 million of its common stock, preferred stock, depositary shares, or any combination of these securities for its own account in 1 or more offerings from time to time.
The shelf registration statement, once effective, is intended to provide the company flexibility to conduct registered sales of its securities, subject to market conditions and CryoLife's future capital needs. CryoLife...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bacteriology
Bacteria identified in juice using FT-near infrared spectroscopy - Diagnostics
Diagnosis of meningococcal disease with immunohistochemistry and PCR outlined - Environmental Health
Communication of information from toxic agents registry to public outlined - Food Safety
Vibrio parahaemolyticus quantified in oysters using PCR - Radiation Therapy
Radiation doses in pediatric radiology discussed - Adverse Drug Events
Expert calls for less direct-to-consumer advertising - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
